Adicet Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET) announced participation in two upcoming virtual investor conferences in January 2021. The first, the H.C. Wainwright Bioconnect 2021 Conference, will offer an on-demand presentation beginning January 11, 2021, at 6:00 AM ET. The second event, the B. Riley Securities' Oncology Investor Conference, features a fireside chat on January 20, 2021, at 3:30 PM ET. Both presentations will be accessible via the company’s website. Adicet Bio specializes in developing allogeneic gamma delta T cell therapies for cancer and other diseases.

MENLO PARK, Calif. and BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate in two virtual investor conferences in January.

Details of the events are as follows:

H.C. Wainwright Bioconnect 2021 Conference
The presentation will be available for on-demand viewing starting January 11, 2021 at 6:00 AM ET.

B. Riley Securities' Oncology Investor Conference
Fireside chat on January 20, 2021 at 3:30 PM ET.

A replay of the pre-recorded H.C. Wainwright presentation can be accessed on January 11, 2021 in the investors section of the Company’s website, and a live webcast of the B. Riley presentation can be accessed in the same section of the Company’s website. 

About Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts
Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com

 

FAQ

When will Adicet Bio participate in the H.C. Wainwright Bioconnect 2021 Conference?

Adicet Bio will participate in the H.C. Wainwright Bioconnect 2021 Conference, with a presentation available for on-demand viewing starting January 11, 2021, at 6:00 AM ET.

What is the date of the B. Riley Securities' Oncology Investor Conference?

The B. Riley Securities' Oncology Investor Conference will take place on January 20, 2021, with a fireside chat scheduled for 3:30 PM ET.

Where can I watch the presentations from the investor conferences?

The presentations from both investor conferences can be accessed in the investors section of Adicet Bio's website.

What is Adicet Bio known for?

Adicet Bio, Inc. is known for discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.